Pediatric Hyperkalemia Follow-up

Updated: Jan 08, 2016
  • Author: Michael J Verive, MD, FAAP; Chief Editor: Timothy E Corden, MD  more...
  • Print

Further Outpatient Care

Continuing care relates to the basic disease process that led to the hyperkalemia.

In patients with salt-wasting congenital adrenal hyperplasia, corticosteroid and mineralocorticoid supplementation are necessary.

Continued renal replacement therapy may be needed for patients with acute renal failure.

Patients with chronic mineralocorticoid deficiency require mineralocorticoid supplementation (eg, fludrocortisone).


Patient Education

Teach patients to recognize the symptoms of hyperkalemia, such as palpitations, dizziness, and weakness.